SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ascendis Pharma Reports Sustained Kidney Function Gains in TransCon PTH Trials

Ascendis Pharma said TransCon PTH trials showed sustained kidney function gains for up to five years.

ASND

Related stories